GLP and GCP-Compliant Assay Services for Regulated Studies
Regulatory success in gene therapy, vaccine, and immunotherapy programs depends on robust, compliant data. Accelevir delivers GLP-compliant molecular and immune assays and integrates Good Clinical Practice (GCP) standards for clinical trial biomarker testing.
Technical Capabilities:
- GLP-compliant biodistribution, shedding, and genome integrity studies.
- GCP-aligned immune monitoring for clinical trials.
- Comprehensive documentation for regulatory submissions.
- Audit-ready SOPs and QA oversight.
Why Partner with Accelevir:
- Proven compliance with FDA, EMA, and ICH guidelines.
- Integration of preclinical and clinical assay strategies.